CBER says firm's activator kit exceeds scope of the pharmacy practice.(Human drugs/Biologics): An article from: Validation Times

This digital document is an article from Validation Times, published by Washington Information Source on February 1, 2004. The length of the article is 435 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: CBER says firm's activator kit exceeds scope of the pharmacy practice.(Human drugs/Biologics)
Author: Dawn Gould
Publication:Validation Times (Newsletter)
Date: February 1, 2004
Publisher: Washington Information Source
Volume: 6 Issue: 2 Page: 10

Distributed by Thomson Gale